EUTM file information

018315563

COVAXX


September 29, 2020

Trademark Summary

The trademark COVAXX was filed by C19 Corp., a U.S. corporation (the "Applicant"). The application was published for oppositions on December 16, 2020, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on March 16, 2021 by Vaxxinova International B.V. on Likelihood of confusion. the opponent was represented by BAKKER & VERKUIJL B.V. and its proceedings were handled in English The second opposition filed on January 11, 2021 by Sanofi Pasteur Europe on Likelihood of confusion. the opponent was represented by CASALONGA ALICANTE, S.L. and its proceedings were handled in English

The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on December 10, 2020.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations and therapeutics for the treatment or prevention of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders
    2. Vaccines
    3. All the aforesaid goods not for ‎and excluding veterinary use‎.
  • The mark was filed in class 42 with Pharmaceutical and therapeutics research and development and all the aforesaid services not for ‎and excluding veterinary use‎..
  • The mark was filed in class 44 with Medical testing for diagnostic or treatment purposes and all the aforesaid services not for ‎and excluding veterinary use‎..